2023
Changes to Prenatal Care Visit Frequency and Telehealth
Konnyu K, Danilack V, Adam G, Peahl A, Cao W, Balk E. Changes to Prenatal Care Visit Frequency and Telehealth. Obstetrics And Gynecology 2023, 141: 299-323. PMID: 36649343, DOI: 10.1097/aog.0000000000005046.Peer-Reviewed Original ResearchConceptsRoutine prenatal careHealth care professionalsPrenatal careVisit scheduleTheoretical Domains FrameworkCare professionalsPrenatal care deliveryRoutine prenatal visitsHigh-risk pregnanciesGRADE-CERQual toolQuality of careCare visitsPrenatal visitQuantitative evidence synthesisCochrane DatabaseRoutine visitsClinic capacityTelevisitsSTUDY SELECTIONClinician's perspectiveCare modelPatientsPractice centerCare deliveryHealthcare Research
2020
Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19
Zaorsky NG, Yu JB, McBride SM, Dess RT, Jackson WC, Mahal BA, Chen R, Choudhury A, Henry A, Syndikus I, Mitin T, Tree A, Kishan AU, Spratt DE. Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19. Advances In Radiation Oncology 2020, 5: 26-32. PMID: 33145460, PMCID: PMC7598436, DOI: 10.1016/j.adro.2020.10.003.Peer-Reviewed Original ResearchProstate cancerM1 diseaseNational Comprehensive Cancer Network risk groupClinical node-positive diseaseFavorable intermediate-risk diseaseRadiation therapy recommendationsIntermediate-risk diseaseNeoadjuvant hormone therapyNode-positive diseaseStage of diseaseTreatment of patientsProstate cancer stageRadiation oncology departmentsGlobal pandemicAdjuvant radiationModerate hypofractionationHormone therapyPositive diseaseRoutine visitsCancer stageTherapy recommendationsOncology departmentRisk groupsRadiation therapyTelemedicine consultationsProstate Cancer Radiation Therapy Recommendations in Response to COVID-19
Zaorsky NG, Yu JB, McBride SM, Dess RT, Jackson WC, Mahal BA, Chen R, Choudhury A, Henry A, Syndikus I, Mitin T, Tree A, Kishan AU, Spratt DE. Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19. Advances In Radiation Oncology 2020, 5: 659-665. PMID: 32292839, PMCID: PMC7118610, DOI: 10.1016/j.adro.2020.03.010.Peer-Reviewed Original ResearchProstate cancerM1 diseaseNational Comprehensive Cancer Network risk groupClinical node-positive diseaseFavorable intermediate-risk diseaseRadiation therapy recommendationsIntermediate-risk diseaseNeoadjuvant hormone therapyNode-positive diseaseStage of diseaseTreatment of patientsProstate cancer stageRadiation oncology departmentsGlobal pandemicAdjuvant radiationModerate hypofractionationHormone therapyPositive diseaseRoutine visitsCancer stageTherapy recommendationsOncology departmentRisk groupsRadiation therapyTelemedicine consultations
2007
Brain natriuretic peptide and impedance cardiography to assess volume status in peritoneal dialysis patients.
Granja CA, Tailor PT, Gorban-Brennan N, Francis J, Bekui A, Finkelstein FO. Brain natriuretic peptide and impedance cardiography to assess volume status in peritoneal dialysis patients. Advances In Peritoneal Dialysis 2007, 23: 155-60. PMID: 17886624.Peer-Reviewed Original ResearchConceptsBrain natriuretic peptidePeritoneal dialysis patientsVolume statusClinical assessmentDialysis patientsNatriuretic peptideEnd-stage renal diseaseStable peritoneal dialysis patientsChronic PD patientsPlasma BNP concentrationSystolic blood pressureLogistic regression analysisHypovolemic groupPD facilitiesBNP concentrationsBlood pressureRenal diseaseDiastolic pressurePD patientsRoutine visitsClinical evaluationBioimpedance cardiographySupine positionExclusion criteriaPatients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply